About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Cancer: bladder
Cancer: brain
Cancer: breast
Cancer: gastroenterological
Cancer: gynaecological
Cancer: haematological
Cancer: kidney
Cancer: lung
Cancer: other
Cancer: pancreas
Cancer: prostate
Cancer: skin
Leukaemia
Lymphoma
Radiotherapy
651 library items
in Cancer: breast
Filter results by:
Date Published
2012 (14)
2011 (122)
2010 (112)
2009 (103)
2008 (83)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Oncology (
remove
)
,
Cancer: breast (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 651
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Horizon scanning: FDA Grants priority review of pertuzumab for untreated HER2-Positive metastatic breast cancer
Source:
BioSpace
,
Date published:
08/02/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: breast
|
Food &Drug Administration (FDA)
|
Licence extension
NeLM
Area:
News
Link
2.
Subanalysis of the MAP.3 study finds exemestane for primary prevention of breast cancer worsens age-related BMD decreases
Source:
Lancet Oncology
,
Date published:
07/02/2012
Category:
8.3.4 Hormone antagonists
|
Adverse Drug Reactions
|
Cancer: breast
NeLM
Area:
News
Link (abstract)
Comment
MAP.3 study results (NeLM report)
3.
NICE issues preliminary guidance (ACD) on four tests to guide selection of chemotherapy regimes in breast cancer management
Source:
NICE
,
Date published:
07/02/2012
Category:
Cancer: breast
|
Clinical guidelines
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
News
Link
Press release
4.
London Cancer New Drugs Group Rapid Review: Lapatinib with capecitabine following disease progression on trastuzumab for metastatic breast cancer
Source:
London Cancer New Drugs Group
,
Date published:
07/02/2012
Category:
8.1 Cytotoxic drugs
|
8.1.5 Other antineoplastic drugs
|
Cancer: breast
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Specific Reviews
Lapatinib_review
5.
Draft NICE guidance says more evidence needed on new test to guide breast cancer treatment decisions
Source:
NICE
,
Date published:
03/02/2012
Category:
Cancer: breast
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
News
Press release
Draft guidance
6.
Mammography screening and hormone treatment use have similar contributions on the incidence of invasive breast cancer
Source:
BMJ
,
Date published:
31/01/2012
Category:
6.4.1 Female sex hormones
|
Cancer: breast
NeLM
Area:
News
Link
Editorial
7.
Tamoxifen and anastrozole as a sequencing strategy in postmenopausal patients with endocrine-responsive early breast cancer
Source:
JCO
,
Date published:
27/01/2012
Category:
8.3.4 Hormone antagonists
|
Cancer: breast
NeLM
Area:
News
Study abstract
8.
RCTs: Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer
Source:
N Engl J Med
,
Date published:
26/01/2012
Category:
8.1 Cytotoxic drugs
|
8.1.5 Other antineoplastic drugs
|
Cancer: breast
NeLM
Area:
News
Link to NSABP study- full text access restricted to subscribers
Link to GeparQuinto study- full text access restricted to subscribers
9.
Carpal tunnel syndrome and musculoskeletal symptoms after exemestane or tamoxifen following 2 to 3 years of tamoxifen: retrospective analysis of Intergroup Exemestane Study
Source:
Lancet Oncology
,
Date published:
20/01/2012
Category:
8.3.4 Hormone antagonists
|
Adverse Drug Reactions
|
Cancer: breast
|
Musculoskeletal syndromes (including chronic fatigue and Gulf war syndromes)
NeLM
Area:
News
Abstract
Link to Comment
10.
Neoadjuvant anastrozole vs. tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): RCT
Source:
Lancet Oncology
,
Date published:
20/01/2012
Category:
8.3.4 Hormone antagonists
|
Cancer: breast
NeLM
Area:
News
Abstract
Link to Comment
Results 1 - 10 of 651
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next